The current price of Yervoy, a medication used in cancer treatment, can vary based on factors such as dosage, location, and insurance coverage. However, according to Drug Patent Watch, the cost of Yervoy can be significant due to its classification as a biologic drug[1]. Reuters also notes that Yervoy is among the more expensive cancer drugs on the market, with a price tag of around $30,000 per dose[2]. Medical News Today highlights that the high cost of Yervoy can pose challenges for patients and healthcare systems, leading to discussions about the value and affordability of such treatments[3].

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/YERVOY
[2] https://www.reuters.com/article/idUSKBN1750FT/
[3] https://www.medicalnewstoday.com/articles/drugs-yervoy